<![CDATA[AGC Biologics 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=42486>Sun, 26 Apr 2026 12:33:48 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[AGC Biologics Partners with Rarity PBC to Advance Life-Saving Gene Therapy for “Bubble Baby Disease”]]>https://www.newswire.co.kr/newsRead.php?no=1021371Fri, 24 Oct 2025 15:50:00 +0900<![CDATA[AGC 바이오로직스, 레러티 PBC와 협력해 ‘거품 아기 병’에 대해 생명을 구하는 유전자 치료법 발전]]>https://www.newswire.co.kr/newsRead.php?no=1021372Fri, 24 Oct 2025 15:50:00 +0900<![CDATA[AGC Biologics Supports Commercial Production of Provention Bio’s New Type 1 Diabetes (T1D) Therapy, TZIELD™]]>https://www.newswire.co.kr/newsRead.php?no=960263Wed, 25 Jan 2023 15:35:00 +0900<![CDATA[AGC Biologics, Provention Bio의 새로운 제1형 당뇨병(T1D) 치료제 TZIELD™의 상업 생산 지지]]>https://www.newswire.co.kr/newsRead.php?no=960264Wed, 25 Jan 2023 15:35:00 +0900